Skip to content

Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, sold RAPP on Jun 30, 2026

Data as of Oct 16

▼ SELL$140K3,308 shares at $42.17Cheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.
Watch RAPP
Traded
Jun 30, 2026
Disclosed
Jul 1, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, sold RAPP on Jun 30, 2026TRADEDDISCLOSED
RAPPSimilar stocks (S&P 500 (SPY)), rebased to RAPP's price on the disclosure day
RAPP since disclosure
−30.0%
after the sale
Similar stocks (SPY) since disclosure
+2.3%
S&P 500 (SPY)

Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$157Kdisclosed Jul 1 · filed 1 day after the trade
  2. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$76.2Kdisclosed Jul 1 · filed 1 day after the trade
  3. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$43.2Kdisclosed Jul 1 · filed 1 day after the trade

See every trade on RAPP →